INTRODUCTION
The properdin system, described by Pillemer et al. in 1954 (1) and Pillemer in 1955 (2) has been shown to inactivate C3, after interaction with zymosan, without significant inactivation of the earlier complement components. This discovery lead to extensive experimental work, but the nature and biological role of properdin remained controversial. Properdin has not been shown to be important in the pathogenesis of human disease. However, in a recent publication by Gewurz et al (3) , it was shown that serum levels of properdin were regularly decreased in patients with acute glomerulonephritis (AGN), ' and in approximately one-half of paDr. Boyer's present address is the Department of Internal Medicine, College of Medicine, Tucson, Arizona 85721.
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tients and chronic membranoproliferative glomerulonephritis with hypocomplementemia (HCGN).
The present study was undertaken in order to clarify the possible involvement of properdin in immunologic kidney diseases, particularly those with decreased levels of serum complement. This investigation was made possible by the recent report of Pensky et al (4) which describes a method for obtaining highly purified human properdin.
METHODS
The diagnosis of specific renal diseases was made on the basis of clinical history, physical findings, laboratory analysis, and renal histopathology as outlined in previous publications (5, 6) . Tissue obtained by kidney biopsy and nephrectomy over a 4 month period of time was studied by immunofluorescent and light microscopy. In addition, material obtained by percutaneous kidney biopsy from patients with AGN and HCGN during the previous 12 months and kept in isopentane at -70°C was also studied. The tissue was used only if the immunofluorescent staining for IgG, ,p1C, and fibrin had not changed during the period of storage compared to the staining of the fresh tissue. Tissue from 97 patients was available for this study. Rabbit antisera produced according to methods previously described (7, 8) were tagged with fluorescein isothiocyanate (FITC) by the method of Wood, Thompson, and Goldstein (9) , as modified in our laboratory (8) . Two FITC-tagged antisera to human C3 were used, one prepared by immunizing rabbits with human 81C isolated according to Miiller-Eberhard, Nilsson , and Aronsson (10) (referred to in this publication as anti-flC), the other with 81C absorbed to zymosan (11) (referred to as anti-fi1C-Z). Rabbit antisera to Clq (kindly provided by Dr. R. M. Stroud) and C4 (12) (kindly provided by Dr. H. Muiller-Eberhard), and goat antisera to antigenic components of C3 (components B, A, and D) (13) (kindly provided by Dr. Clark West) were used for indirect staining with FITC-tagged goat anti-rabbit or rabbit anti-goat IgG in the in the second layer. Antiserum to properdin was prepared by injecting rabbits at multiple sites with 0.5 mg human properdin, purified according to Pensky et al (4) , mixed with complete Freund's adjuvant. After 5 wk a booster injection was given and the rabbits were bled on several occasions. IgG was isolated from the antiserum and labeled with FITC (8, 9) . The specificity of the anti-properdin, anti-p1,C and anti-,fiC-Z sera was studied by absorption, double diffusion in agar (14) , and immunoelectrophoresis (15 Table I .
In double diffusion in agar, the antiserum to properdin gave one line with normal human serum showing a reaction of identity with the line formed between properdin and antiproperdin ( Fig. 1 a) . Anti-properdin did not react with purified Clq (11S), C3 (PC), or CS. The anti-PiC serum did not react with the purified properdin but the anti-,8pC-Z gave a weak precipitation reaction with properdin ( Fig. 1 b) which could be removed by absorption with properdin ( Fig. 1 c) . In immunoelectrophoresis against fresh or aged human serum, anti-PiC was found to react with PiC and PA, while anti-PiC-Z reacted with PA only.
In the staining of kidney tissue, it was repeatedly observed that many sections that stained strongly for properdin did not stain with one or more of the antisera to IgG, IgM, fibrin, Clq, and C4 and vice versa. All properdin-positive glomeruli reacted with anti-PiC serum; however, renal tissue from patients with other diseases frequently contained PiC but not properdin. Tubular cells and casts in the tubular lumina often stained for P1C, but only in a few cases for properdin.
Results of immunofluorescent studies (Table II) . All eight patients with chronic membranoproliferative glomerulonephritis with low serum levels of C3 showed positive glomerular staining for properdin. The staining had a characteristic lobular distribution in six cases (Fig. 2) , and showed a coarse deposition of properdin on the basement membrane without clear lobulation in two other cases (Fig. 3) ; the staining for properdin had always the same distribution as that for SAC. Clq and C4 were found in 3/5 and 4/5 biopsies respectively (Table III) . In four cases, the staining for IgG was (>) indicates that the highest amount used did not diminish the staining. * After addition of undiluted antiserum to three parts of human serum, the staining became negative. (5) . All eight patients with acute poststreptococcal glomerulonephritis had strongly positive glomerular fluorescence for properdin. In three cases the distribution was mostly peripheral with characteristic "humps" (Fig. 4) on the basement membrane while in the other five both ,8,C and properdin were found predominantly in the mesangium (Fig. 5 ). This type of immunofluorescent pattern has been described for jPiC late in acute poststreptococcal glomerulonephritis (18 of PiC and a trace positive deposition of properdin in the mesangial stalk and in the glomerular arterioles. Tissues showing "trace" staining are not included in Table  II . In no other cases was properdin found. No glomerular deposition of properdin was observed in kidney tissue from patients with vasculitis, periarteritis nodosa, Goodpasture's syndrome, hemolytic anemia-uremia syndrome, and cryoglobulinemia with nephritis.
DISCUSSION
The isolation of properdin and several components of the classical complement sequence in a chemically and immunologically pure form has now made it possible to attack the problems of inactivation of complement independent of antigen-antibody complexes with more confidence than was possible when properdin was first described. Highly purified human properdin was shown by Pensky et al (4) to be unrelated to the immunoglobulins on the basis of physical, chemical, and antigenic properties and by its functional behavior in immunologic systems. Antigenic determinants in common with Clq, C3, C4, or C5 were not found. The properdin antiserum in the present investigation often did not react in immunofluorescence with renal tissue that stained for IgG, IgM, albumin, fibrin, Clq, C4, and C3 and its staining properties were abolished only by absorptions with properdin and not affected by the addition of iGC, Clq, and C5. Not unexpectedly, it was found that the antiserum to PiC prepared after absorption of complement to zymosan (anti-PiC-Z) contained antibodies to both 81C/P1A and properdin.
This investigation has shown that in all cases of AGN and HCGN that we have studied, properdin is deposited in the glomeruli. In other diseases, even with intense immunofluorescence for PiC and/or IgG, properdin was, as a rule, not found (Table II) found deposited in the glomeruli in AGN and HCGN (5, 6, 18) . Although this phenomenon can be observed late in "one shot" serum sickness in rabbits (19) , it is not seen acutely or in the chronic disease model. Secondly, there is depression of C3 and terminal complement components in the serum with C1, C4, and C2 not being significantly decreased (20) . Thirdly, a heatlabile anticomplementary factor is present in sera from patients with AGN and HCGN that can inactivate guinea pig C3 (21) or in the case of HCGN human C3 (22) . In the latter disease a cofactor is lacking which is present in normal human serum or the pseudoglobulin fraction prepared from normal serum. Properdin, being a euglobulin, is probably distinct from this cofactor. The possibility that properdin may be one of the factors involved in this inactivation of C3 became The immunological injury to the kidney in glomerulonephritis, recently reviewed by Dixon (26) and by Fish, Michael, and Good (27) Note added in proof. Since the completion of this manuscript, we have noticed in the glomeruli of two patients with SLE, a weak staining for properdin together with a heavy deposition of 81C.
